RecruitingNCT04239079

Autoimmune Features of Neurodegenerative Disorders


Sponsor

Columbia University

Enrollment

120 participants

Start Date

May 1, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

This study is being conducted to better understand the role of inflammation in Parkinson's disease (PD) and Alzheimer's disease (AD). The investigators plan to recruit 30 PD, 30 AD/Amnestic Mild Cognitive Impairment (aMCI), and 60 age matched healthy controls in this study to study the role of immune response in PD and AD. The study involves up to two study visits involving brief questionnaires and blood draw of up to 250cc (approximately 17 tablespoons) to be collected. More ways to participate, including 1) smaller amount blood donation (up to 100cc per visit for 1-2 visits); and 2) participation via tele-visit and mobile phlebotomy visits (blood donation up to 50cc, \~5 tubes, by a certified mobile phlebotomist at home/location of choice) now available.


Eligibility

Min Age: 55 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether Parkinson's disease and other neurodegenerative conditions (diseases that damage the brain over time) may have an autoimmune component — meaning the immune system may be mistakenly attacking the brain. Researchers will compare immune system markers in Parkinson's patients versus healthy controls. **You may be eligible if...** - You are 55 or older - You have a confirmed clinical diagnosis of Parkinson's disease (with tremor, rigidity, or slow movements that respond to dopaminergic medication), with motor symptoms starting after age 45, OR - You are a healthy person aged 55 or older with no family history of Parkinson's disease, willing to participate as a control - You are willing to undergo genetic testing **You may NOT be eligible if...** - You have atypical features suggesting a different type of Parkinson-like disorder - You have a history of dementia - You have had cancer in the last 3 years (excluding skin cancer) - You have an autoimmune disease or immune system disorder - You are on chronic immune-modifying medications (such as oral steroids or rituximab) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Columbia University Medical Center

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04239079


Related Trials